(Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that REVTORPYK™ (gedatolisib) in combination ...

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network, on World Cancer Day, observed February 4, highlighted its free patient guidelines aimed at helping people navigate a cancer diagnosis, ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive ...

PLYMOUTH MEETING, PA [October 9, 2025] — New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower ...

Outcomes of patients with metastatic solid cancers treated on early phase clinical trials in western Australia. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...

Today, the National Comprehensive Cancer Network ® (NCCN ®)-a nonprofit responsible for globally utilized guidelines for cancer care-is sharing new NCCN Guidelines Navigator™ resources for breast ...

Please provide your email address to receive an email when new articles are posted on . Christopher H. Lieu, MD, has been elected vice chair. “The exemplary leadership from our board of directors is ...

The NCCN Guidelines for MPNs have seen frequent updates recently, reflecting new therapeutic approvals and options for patients. Emphasis on clinical trials as preferred treatment options highlights ...

Today, the National Comprehensive Cancer Network ® (NCCN ®)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and ...

PLYMOUTH MEETING, PA [April 29, 2026] — The National Comprehensive Cancer Network ® (NCCN ®)—an alliance of leading cancer centers—announces several recent external awards and publications honoring ...

The National Comprehensive Cancer Network (NCCN) and OpenEvidence, an AI-enabled medical information platform for doctors, announced a licensing agreement to make NCCN’s evidence-based oncology ...

Trends in mortality from endocrine neoplasms in the United States: A CDC WONDER analysis (1999–2020). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...